- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Lu-177 PSMA vs Comparator Treatments and Survival in Metastatic Castration-Resistant Prostate Cancer.
September 19, 2024
Prediction of undetectable circulating tumor DNA by comprehensive genomic profiling assay in metastatic prostate cancer: the SCRUM-Japan MONSTAR SCREEN project.
September 19, 2024
Survival of men with metastatic hormone-sensitive prostate cancer and adrenal-permissive HSD3B1 inheritance.
September 19, 2024
Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancer.
September 19, 2024
BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity.
September 19, 2024
Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer.
September 19, 2024
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer.
September 19, 2024
Trifecta Outcomes After Use of 3-Dimensional Digital Models for Planning of Robotic Prostatectomy: A Secondary Analysis of a Randomized Clinical Trial.
September 18, 2024
Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in Primary Staging and Therapeutic Decision-Making.
September 18, 2024
Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study.
September 18, 2024
Risk factors for Gleason score upgrade from prostate biopsy to radical prostatectomy.
September 18, 2024
A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer.
September 18, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.
September 18, 2024
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis.
September 18, 2024